Tag

During the webcast, management will deliver financial results, operational updates, and provide comments on recent growth and M&A initiatives announced in the period since the company listed its shares on Nasdaq

Flora Growth Corp (NASDAQ: FLGC) last month became the first ever cannabis cultivator to list on the NASDAQ stock exchange in the US without using a SPAC (Special Purpose Acquisition Company), reverse merger, or dual listing, and became the first all-outdoor cannabis grower to...

Antioquia's new secretary of economic development has obviously done her homework, and has a lot to say on the goals she and the governor's administration has for the area. In this interview, Daniela Trejo speaks with Finance Colombia's Loren Moss on Antioquia's rapid growth,...

Khiron is now shipping its branded EU-GMP certified medical cannabis to Germany, providing immediate access to the German market through its distribution partner, Nimbus Health GmbH. Khiron teams continue to educate physicians with plans to leverage clinical evidence from both...

Like several other companies in Colombia, Khiron (TSX.V: KHRNF) cultivates and processes cannabis at its agricultural facilities in Ibagué, Tolima. But Khiron takes the unique approach of launching and operating a chain of integrative medical clinics under its Zerenia brand,...

Khiron Life Sciences this week announced that it has received manufacturing quotas from the Colombian TQG that authorize the company to manufacture high-THC whole plant extract for both export and domestic purposes.

The UN body allocated 131,000 pounds of dried marijuana flower production to Colombia, 21.84% of the entire world total.

Khiron Life Sciences Corp. ( (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), has announced that its wholly-owned clinic network, the Latin American Institute of Neurology and the Nervous System (“ILANS”), has partnered with Colombian health insurance company...

"There has been a lot of progress," said Lagos. "In Chile, the fact that [legalizing] the personal consumption of medicinal cannabis is being discussed is a sign of progress."

The Canadian company with its main operations in Colombia sold more than 14.3 million common shares for $0.90 per share to raise the funding.